{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T04:07:27Z","timestamp":1777522047538,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.comppsych.2017.03.011","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T11:33:53Z","timestamp":1490614433000},"page":"113-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia"],"prefix":"10.1016","volume":"76","author":[{"given":"Rui","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.comppsych.2017.03.011_bb0005","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1371\/journal.pmed.0020141","article-title":"A systematic review of the prevalence of schizophrenia","volume":"2","author":"Saha","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-859X-8-12","article-title":"Schizophrenia pathophysiology: are we any closer to a complete model?","volume":"8","author":"Lakhan","year":"2009","journal-title":"Ann Gen Psychiatry"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1017\/S1461145714000157","article-title":"Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome","volume":"17","author":"Paredes","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0020","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1017\/S0033291715001282","article-title":"Pituitary gland volume and psychosocial stress among children at elevated risk for schizophrenia","volume":"45","author":"Cullen","year":"2015","journal-title":"Psychol Med"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neubiorev.2016.12.013","article-title":"The neural diathesis-stress model of schizophrenia revisited: an update on recent findings considering illness stage and neurobiological and methodological complexities","volume":"73","author":"Pruessner","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.steroids.2015.03.014","article-title":"Neuroactive steroids and the peripheral nervous system: an update","volume":"103","author":"Giatti","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0035","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1007\/s00213-015-4046-3","article-title":"DHEA metabolism to the neurosteroid androsterone: a possible mechanism of DHEA's antidepressant action","volume":"232","author":"Ben Dor","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.yhbeh.2014.12.012","article-title":"The neurosteroid dehydroepiandrosterone sulfate, but not androsterone, enhances the antidepressant effect of cocaine examined in the forced swim test--possible role of serotonergic neurotransmission","volume":"70","author":"Krzascik","year":"2015","journal-title":"Horm Behav"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0045","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1440-1819.2011.02252.x","article-title":"Serum cortisol and dehydroepiandrosterone- sulfate levels in schizophrenic patients and their first-degree relatives","volume":"65","author":"Osman","year":"2011","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0050","series-title":"Classification and diagnostic criteria of mental disorders in China","first-page":"62","volume":"23","author":"Psychiatric branch of Chinese medical association","year":"2001"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.schres.2015.07.011","article-title":"Cluster analysis differentiates high and low community functioning in schizophrenia: subgroups differ on working memory but not other neurocognitive domains","volume":"168","author":"Alden","year":"2015","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0060","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0065","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3889\/oamjms.2015.018","article-title":"Association between serum cortisol and DHEA-S levels and response to antipsychotic treatment in schizophrenia","volume":"3","author":"Zoja","year":"2015","journal-title":"Maced J Med Sci"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0070","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1570159X11666131120224950","article-title":"Glucocorticoid regulates parkin expression in mouse frontal cortex: implications in schizophrenia","volume":"12","author":"Pandya","year":"2014","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0075","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0893-133X(00)00201-3","article-title":"The blunted plasma cortisol response to apomorphine and its relationship to treatment response in patients with schizophrenia","volume":"24","author":"Meltzer","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0080","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/pon.3804","article-title":"Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients","volume":"24","author":"Amidi","year":"2015","journal-title":"Psychooncology"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2015.07.417","article-title":"The programming of the stress response network by early-life adversity","volume":"61","author":"Pruessner","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2011.06.002","article-title":"P-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission","volume":"224","author":"Onogi","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0095","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/cne.23811","article-title":"Immunogold characteristics of VGLUT3-positive GABAergic nerve terminals suggest corelease of glutamate","volume":"523","author":"Stensrud","year":"2015","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.12740\/PP\/30180","article-title":"The stabilizing effect of dehydroepiandrosterone on clinical parameters of metabolic syndrome in patientswith schizophrenia treated with olanzapine- a randomized, double-blind trial","volume":"49","author":"Holka-Pokorska","year":"2015","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0105","first-page":"187","article-title":"Metabolic syndrome and cortisol\/DHEAS ratio in patients with bipolar disorder and schizophrenia","volume":"26","author":"Vuksan-\u0106usa","year":"2014","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0110","first-page":"687","article-title":"Increased serum dehydroepiandrosterone sulfate in the first episode but not in subsequent episodes in male patients with schizophrenia","volume":"29","author":"Beyazy\u00fcz","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.schres.2006.11.020","article-title":"Plasma cortisol-dehydroepiandrosterone (DHEA) ratios in schizophrenia and bipolar disorder","volume":"90","author":"Gallagher","year":"2007","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2017.03.011_bb0120","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neubiorev.2014.09.004","article-title":"HPA axis response to social stress is attenuated in schizophrenia but normal in depression: evidence from a meta-analysis of existing studies","volume":"47","author":"Ciufolini","year":"2014","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X16306617?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X16306617?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T18:34:54Z","timestamp":1757874894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X16306617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":24,"alternative-id":["S0010440X16306617"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2017.03.011","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2017.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}